Interventional firm C.R. Bard has acquired assets relating to self-expanding nitinol stent technology from PST of Gainesville, FL. Terms of the deal were not disclosed.
The technology includes a development-stage stent specifically designed to have the flexibility to meet the needs of tortuous and dynamic anatomy, according to the Murray Hill, NJ-based firm.
As part of the transaction, Bard said it would record an acquisition-related research and development charge of approximately $6 million in the first quarter of 2006.
By AuntMinnie.com staff writers
January 18, 2006
Related Reading
Bard ups Q1 guidance, March 16, 2005
Robust Q3 for Bard, October 20, 2004
Reinsdorf joins Bard, October 15, 2004
ConMed completes Bard endoscopic acquisition, October 1, 2004
Settlement in Immunomedics patent case, September 30, 2004
Copyright © 2006 AuntMinnie.com
